A major step forward toward biosensor devices that can provide fast, high-contrast detection of biomarkers in almost any environment are ‘binding-activated fluorescent biosensors.’ Now, a research collaboration has developed a synthetic biology platform that streamlines their up-until-now tedious and expensive discovery, as well as their molecular evolution and cost-effective manufacturing, opening a plethora of new biomedical and environmental opportunities.